The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 05, 2024
Filed:
Jan. 10, 2020
Applicant:
Calgent Biotechnology Co., Ltd., Taipei, TW;
Inventors:
Assignee:
Calgent Biotechnology Co., Ltd., Taipei, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/166 (2006.01); A61K 31/167 (2006.01); A61K 31/337 (2006.01); A61K 31/4409 (2006.01); A61K 31/475 (2006.01); A61K 31/506 (2006.01); A61K 31/593 (2006.01); A61K 31/704 (2006.01); A61K 33/24 (2019.01); A61P 3/10 (2006.01); A61P 25/28 (2006.01); A61P 35/02 (2006.01); A61P 37/00 (2006.01); C07D 209/04 (2006.01); C07D 213/74 (2006.01); C07D 213/75 (2006.01); C07D 213/76 (2006.01); C07D 215/40 (2006.01); C07D 215/42 (2006.01); C07D 231/38 (2006.01); C07D 235/30 (2006.01); C07D 239/42 (2006.01); C07D 241/04 (2006.01); C07D 241/20 (2006.01); C07D 277/42 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 213/75 (2013.01); A61K 31/166 (2013.01); A61K 31/167 (2013.01); A61K 31/4409 (2013.01); A61P 3/10 (2018.01); A61P 25/28 (2018.01); A61P 35/02 (2018.01); A61P 37/00 (2018.01); C07D 209/04 (2013.01); C07D 213/74 (2013.01); C07D 213/76 (2013.01); C07D 215/40 (2013.01); C07D 215/42 (2013.01); C07D 231/38 (2013.01); C07D 235/30 (2013.01); C07D 239/42 (2013.01); C07D 241/04 (2013.01); C07D 241/20 (2013.01); C07D 277/42 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); A61K 31/337 (2013.01); A61K 31/475 (2013.01); A61K 31/506 (2013.01); A61K 31/593 (2013.01); A61K 31/704 (2013.01); A61K 33/24 (2013.01); A61K 2300/00 (2013.01);
Abstract
The invention relates to compounds of formula (I) with low cytotoxicity for blocking the ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, cancers.